Shannon Rourke Devens
Corporate Officer/Principal bei SURFACE ONCOLOGY, INC.
Ursprung des Netzwerks ersten Grades von Shannon Rourke Devens
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 26 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shannon Rourke Devens
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Chairman Corporate Officer/Principal Director/Board Member Director/Board Member | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Arteaus Therapeutics LLC
 Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Private Equity Investor Director of Finance/CFO | |
| DYAX CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Investor Relations Contact | |
| MIRATI THERAPEUTICS | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Miscellaneous Commercial Services | Investor Relations Contact | |
| SERES THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Columbia University College of Physicians & Surgeons | College/University | Graduate Degree | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| Arizona State University | College/University | Undergraduate Degree | |
Shire, Inc.
 Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Pharmaceuticals: Major | Public Communications Contact | |
LV Management Group, LLC
 LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Investment Managers | Private Equity Investor | |
| Hartwick College | College/University | Undergraduate Degree | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director of Finance/CFO | |
| Notre Dame College (Ohio) | College/University | Undergraduate Degree | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO | |
| LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree | |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
Old Mother Hubbard, Inc.
 Old Mother Hubbard, Inc. Food: Specialty/CandyConsumer Non-Durables Old Mother Hubbard, Inc. manufactures and distributes snacks and biscuits for dogs in the United States. It bakes a wide variety of naturally delicious snacks for dogs with, all-natural ingredients including chicken, cheddar cheese, apples, carrots, sweet potatoes and oatmeal. The company was founded in 1926 and is headquartered in Tewksbury, MA. | Food: Specialty/Candy | Comptroller/Controller/Auditor | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Symic Bio, Inc.
 Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Chairman | |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Pharmaceuticals: Major | Director/Board Member | |
Symic Holdings LLC
 Symic Holdings LLC BiotechnologyHealth Technology Symic Holdings LLC develops new category of therapeutics. The company was founded by John Paderi, Kate Stuart and Alyssa Panitch and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member | |
| Abshanafelt Advisory | President |
Statistik
International
| Vereinigte Staaten | 48 |
| Schweiz | 2 |
| Irland | 2 |
| Australien | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 85 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 40 |
| Chairman | 25 |
| Chief Tech/Sci/R&D Officer | 23 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Daniel Lynch | 32 |
| Dave Grayzel | 23 |
| Charles Sigal | 20 |
| Denice Torres | 19 |
| Armen Shanafelt | 17 |
| J. Goater | 17 |
| Laurie Stelzer | 13 |
| Scott C. Chappel | 12 |
| Vito Palombella | 11 |
| Cameron McDonough | 11 |
| Alison O'Neill | 10 |
| Carsten Brunn | 10 |
| Benjamin Hickey | 9 |
| Henry Rath | 9 |
| Wendy Dwyer | 8 |
- Börse
- Insiders
- Shannon Rourke Devens
- Unternehmensverbindungen
